Cefdinir cas no:91832-40-5
Synonyms: Cefzon;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl) (hydroxyimino)acetyl)amino)-3-ethenyl-8-oxo-, (6R-(6alpha,7beta(Z)))-;Cefdinirum [INN-Latin];(6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyimino-acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;Cefdinir [USAN:INN];(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyimino-acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;Cefzon (TN);Omnicef;(-)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-oxime;Omnicef (TN);Cefdinyl;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic acid,7-[[(2Z)-(2-amino-4- thiazolyl)(hydroxyimino)acetyl]amino]-3- ethenyl-8-oxo-,(6R,7R)-;
NameCefdinir
CAS91832-40-5
SynonymsCefzon;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl) (hydroxyimino)acetyl)amino)-3-ethenyl-8-oxo-, (6R-(6alpha,7beta(Z)))-;Cefdinirum [INN-Latin];(6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyimino-acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;Cefdinir [USAN:INN];(6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyimino-acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;Cefzon (TN);Omnicef;(-)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-oxime;Omnicef (TN);Cefdinyl;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic acid,7-[[(2Z)-(2-amino-4- thiazolyl)(hydroxyimino)acetyl]amino]-3- ethenyl-8-oxo-,(6R,7R)-;
Molecular FormulaC14H13N5O5S2
Molecular Weight395.42
AppearanceWhite powder
refractive index1.861
storage tempRoom temp
Safety
?Moderately toxic by ingestion and intravenous routes. Low toxicity by intraperitoneal and subcutaneous routes. Experimental reproductive effects. When heated to decomposition it emits toxic vapors of NOx and SOx.
1. |
??? |
orl-rat LD50:>5600?mg/kg
|
??? |
IYKEDH ?? Iyakuhin Kenkyu. Study of Medical Supplies. 23 (1992),93. |
2. |
??? |
ipr-rat LD50:>5600?mg/kg
|
??? |
IYKEDH ?? Iyakuhin Kenkyu. Study of Medical Supplies. 23 (1992),93. |
3. |
??? |
scu-rat LD50:>5600?mg/kg
|
??? |
IYKEDH ?? Iyakuhin Kenkyu. Study of Medical Supplies. 23 (1992),93. |
4. |
??? |
ivn-rat LD50:>2?g/kg
|
??? |
IYKEDH ?? Iyakuhin Kenkyu. Study of Medical Supplies. 23 (1992),93. |
5. |
??? |
orl-mus LD50:>5600?mg/kg
|
??? |
IYKEDH ?? Iyakuhin Kenkyu. Study of Medical Supplies. 23 (1992),93. |
6. |
??? |
ipr-mus LD50:>5600?mg/kg
|
??? |
IYKEDH ?? Iyakuhin Kenkyu. Study of Medical Supplies. 23 (1992),93. |
7. |
??? |
scu-mus LD50:>5600?mg/kg
|
??? |
IYKEDH ?? Iyakuhin Kenkyu. Study of Medical Supplies. 23 (1992),93. |
8. |
??? |
ivn-mus LD50:>2?g/kg
|
??? |
IYKEDH ?? Iyakuhin Kenkyu. Study of Medical Supplies. 23 (1992),93. |
9. |
??? |
orl-dog LD50:>1?g/kg
|
??? |
NIIRDN ?? Drugs in Japan. Ethical Drugs, 6th Edition 1982 . Edited by Japan Pharmaceutical Information Center. (Yakugyo Jiho Co., Ltd.,Tokyo, Japan.:?)1995,667. |